Elekta (EKTA B)
Free
No email, no account, no signup.
Pulling latest news for Elekta…
Bull
Bear
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99 $1.25.
Get the deep 4-model report – Signal
HOLD
Sentiment
2/10
Risk
8/10
Get full analysis with Bull/Bear case, catalysts, and risk analysis
Buy express analysis –
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Sentiment has deteriorated further after the CMD: investors are focusing on guidance/targets and uncertainty around growth/order momentum, reinforcing the negative tone already driven by weak Q4 order intake.
Exchange
Nasdaq Stockholm
Sector
Radiotherapy medtech and oncology software
Market Cap
$2.2B
Market sentiment
Sentiment has deteriorated further after the CMD: investors are focusing on guidance/targets and uncertainty around growth/order momentum, reinforcing the negative tone already driven by weak Q4 order intake.
Why HOLD ?
Hold: margin/cash-flow improvements and the cost program are supportive, but weak order intake raises uncertainty around forward revenue; wait for evidence of order recovery (Q1/Q2) before adding.
- Maintain the current position; avoid adding until order intake stabilises and the impact of stricter order acceptance is visible in upcoming quarters.
Recent News
- On 17 June 2026 Elekta held a Capital Markets Day, presenting new mid-term financial targets and more detailed FY 2026/27 guidance. The market reaction was negative, with the share down roughly 5–7% on the day (and remaining weak after CMD).
Bull case
- **FDA clearance** for Elekta Evo can support near-term momentum.
- Early impact from **cost savings** may start to show.
Unlock to read more →
Bear case
- Ongoing **FX and tariff headwinds** may pressure reported results.
Unlock to read more →
Catalysts
27 Aug 2026 — Q1 2026/27 report (first quarter with full savings run-rate)
Dilution Risk
Assessment: Low
Order analysis – $4.99 $1.25
Save hours of research. $4.99 $1.25.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Want to read the full analysis?
Order a fresh analysis of Elekta – ready in your inbox in 5–15 minutes.
- Signal + risk + sentiment
- Bull/Bear case + triggers
- Catalysts with dates
- Saved as a webpage in your account
- Ready in 5–15 min (email when ready)
Full analysis at introductory pricing — 7-day money-back guarantee.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Fact-based analysis
Updated weekly
No commitment period
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.